{"id":"W2889696398","doi":"10.1038/s41416-018-0261-0","title":"Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Pazopanib; Everolimus; Medicine; Oncology; Internal medicine; Clinical endpoint; PI3K/AKT/mTOR pathway; Progression-free survival; Targeted therapy; Cancer; Sunitinib; Chemotherapy; Clinical trial; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007435134,0.0001457101,0.0003838004,0.00007127085,0.00009123714,0.00005022091,0.00007492152,0.00004005779,0.0004200769],"category_scores_gemma":[0.00003002583,0.0001232578,0.00005837314,0.0001582227,0.0001273976,0.000132408,0.00001733622,0.0001789618,0.000004544761],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001336532,"about_ca_system_score_gemma":0.0004075771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000736877,"about_ca_topic_score_gemma":0.0007960821,"domain_scores_codex":[0.9988476,0.00002785664,0.000327857,0.0001735847,0.0003758441,0.0002472726],"domain_scores_gemma":[0.9985149,0.00001979373,0.0002010258,0.00008856229,0.0009321637,0.0002435652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004765192,0.0004337834,0.7998309,0.0000738975,0.0009535596,0.0005253957,0.0003243329,0.000002812221,0.001012229,0.000007815333,0.001110418,0.1909596],"study_design_scores_gemma":[0.01122483,0.0026427,0.9791263,0.000309511,0.0006767787,0.001440468,0.00001558475,0.000007786942,0.001275542,0.00005419088,0.003087656,0.0001386551],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950806,0.003853538,0.00005491044,0.0001449282,0.0001839694,0.0002721914,0.00009654513,0.00001029459,0.0003029948],"genre_scores_gemma":[0.9970365,0.0004666953,0.001075493,0.0005826083,0.0005677184,0.00001004957,0.000005255228,0.000038607,0.000217049],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.190821,"threshold_uncertainty_score":0.5026307,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008266148816195511,"score_gpt":0.2463326452171442,"score_spread":0.2380664964009487,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}